Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.
Adult
Aged
Aged, 80 and over
COVID-19
/ complications
Critical Care
Cross-Sectional Studies
Female
Hospitals, University
/ statistics & numerical data
Humans
Male
Middle Aged
Patient Discharge
/ statistics & numerical data
Prevalence
Survivors
/ statistics & numerical data
United Kingdom
/ epidemiology
Young Adult
SARS CoV-2
acute respiratory distress syndrome
post-COVID syndrome
post-intensive care syndrome
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
08
07
2020
revised:
25
07
2020
accepted:
27
07
2020
pubmed:
31
7
2020
medline:
15
1
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
There is currently very limited information on the nature and prevalence of post-COVID-19 symptoms after hospital discharge. A purposive sample of 100 survivors discharged from a large University hospital were assessed 4 to 8 weeks after discharge by a multidisciplinary team of rehabilitation professionals using a specialist telephone screening tool designed to capture symptoms and impact on daily life. EQ-5D-5L telephone version was also completed. Participants were between 29 and 71 days (mean 48 days) postdischarge from hospital. Thirty-two participants required treatment in intensive care unit (ICU group) and 68 were managed in hospital wards without needing ICU care (ward group). New illness-related fatigue was the most common reported symptom by 72% participants in ICU group and 60.3% in ward group. The next most common symptoms were breathlessness (65.6% in ICU group and 42.6% in ward group) and psychological distress (46.9% in ICU group and 23.5% in ward group). There was a clinically significant drop in EQ5D in 68.8% in ICU group and in 45.6% in ward group. This is the first study from the United Kingdom reporting on postdischarge symptoms. We recommend planning rehabilitation services to manage these symptoms appropriately and maximize the functional return of COVID-19 survivors.
Sections du résumé
BACKGROUND
There is currently very limited information on the nature and prevalence of post-COVID-19 symptoms after hospital discharge.
METHODS
A purposive sample of 100 survivors discharged from a large University hospital were assessed 4 to 8 weeks after discharge by a multidisciplinary team of rehabilitation professionals using a specialist telephone screening tool designed to capture symptoms and impact on daily life. EQ-5D-5L telephone version was also completed.
RESULTS
Participants were between 29 and 71 days (mean 48 days) postdischarge from hospital. Thirty-two participants required treatment in intensive care unit (ICU group) and 68 were managed in hospital wards without needing ICU care (ward group). New illness-related fatigue was the most common reported symptom by 72% participants in ICU group and 60.3% in ward group. The next most common symptoms were breathlessness (65.6% in ICU group and 42.6% in ward group) and psychological distress (46.9% in ICU group and 23.5% in ward group). There was a clinically significant drop in EQ5D in 68.8% in ICU group and in 45.6% in ward group.
CONCLUSIONS
This is the first study from the United Kingdom reporting on postdischarge symptoms. We recommend planning rehabilitation services to manage these symptoms appropriately and maximize the functional return of COVID-19 survivors.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1013-1022Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.
Références
Department of Health and Social Care. Number of Coronavirus (COVID-19) cases in the UK. https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public#number-of-cases-and-deaths. Accessed 8 July 2020.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242.
Carfì A, Bernabei R, Landi F Gemelli Against. COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19 [published online ahead of print July 9, 2020]. JAMA. 2020:e2012603.
Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS) outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52:00063. https://doi.org/10.2340/16501977-2694
NHS-England and NHS-Improvement. After-care needs of inpatients recovering from COVID-19. https://www.england.nhs.uk/coronavirus/publication/after-care-needs-of-inpatients-recovering-from-covid-19/. Accessed 28 June 2020.
Zhang G, Hu C, Luo L, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. https://doi.org/10.1016/j.jcv.2020.104364
EuroQol. EQ-5D available upon request from https://euroqol.org/support/how-to-obtain-eq-5d/
World Health Organization (WHO). The International Classification of Functioning, Disability and Health. https://www.who.int/classifications/icf/en/. Accessed 8 July 2020.
Sivan M, Halpin SJ, Gee J. Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). Adv Clin Neurosci Rehabil. 2020;19(4):14-17.
Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493-500.
Wootton DG, Dickinson L, Pertinez H, et al. A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J. 2017;49:6.
Wyrwich KW, Yu H, Sato R, Powers JH. Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire [published online ahead of print July 30, 2020]. Patient Relat Outcome Meas. 2015;6:215-223.
Wang X, Xu H, Jiang H, et al. The clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study [published online ahead of print May 22, 2020]. QJM. 2020:hcaa178. https://doi.org/10.1093/qjmed/hcaa178
Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics [published online ahead of print May 31, 2020]. Fatigue Biomed Health Behav. 2020. https://doi.org/10.1080/21641846.2020.1778227
Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312-1320.
Wu X, Dong D, Ma D. Thin-section computed tomography manifestations during convalescence and long-term follow-up of patients with severe acute respiratory syndrome (SARS). Med Sci Monit. 2016;22:2793-2799.
Wade D, Hardy R, Howell D, Mythen M. Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review. Minerva Anestesiol. 2013;79(8):944-963.
Bajwah S, Wilcock A, Towers R, et al. Managing the supportive care needs of those affected by COVID-19. Eur Respir J. 2020;55:2000815.
Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicentre study. Am J Gastroenterol. 2020;115(5):766-773. https://doi.org/10.14309/ajg.0000000000000620
Fan E, Dowdy DW, Colantuoni E, et al. Physical complications in acute lung injury survivors: a 2-year longitudinal prospective study. Crit Care Med. 2014;42(4):849-859.
Kamdar BB, Suri R, Suchyta MR, et al. Return to work after critical illness: a systematic review and meta-analysis. Thorax. 2020;75(1):17-27. https://doi.org/10.1136/thoraxjnl-2019-213803
Stam H, Stucki G, Bickenbach J. Covid-19 and post intensive care syndrome: a call for action. J Rehabil Med. 2020;52:jrm00044.
Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401-409. https://doi.org/10.1136/thx.2004.030205
Ong KC, Ng AW, Lee LS, et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur Respir J. 2004;24(3):436-442. https://doi.org/10.1183/09031936.04.00007104